Literature DB >> 32215768

Redo gracilis interposition for complex perineal fistulas.

H Gilshtein1, V Strassman1, S D Wexner2.   

Abstract

BACKGROUND: Rectovaginal, pouch-vaginal, and recto-urethral fistulas are very challenging to treat. Gracilis muscle interposition was shown be an effective treatment for these complex fistulas. The aim of this study was to investigate the feasibility and outcomes of redo gracilis interposition for persistent and recurrent complex perineal fistulas.
METHODS: A retrospective analysis of all patients who had redo gracilis muscle interposition for complex perineal fistulas at our institution from 1995 to 2019 was performed.
RESULTS: Nine patients (5 males, mean age 55 years) were included for analysis. The types of fistulas were recto-urethral (n = 5), rectovaginal (n = 2) and pouch-vaginal (n = 2). The success rate was 56% with 5 patients achieving complete healing of the fistula. Only 1 patient (11%) experienced a postoperative complication.
CONCLUSIONS: Redo gracilis muscle interposition is feasible and safe with promising resultsin healing of complex perineal fistula.

Entities:  

Keywords:  Complex perineal fistula; Gracilis muscle interposition; Redo

Mesh:

Year:  2020        PMID: 32215768     DOI: 10.1007/s10151-020-02185-x

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  12 in total

1.  Analysis of function and predictors of failure in women undergoing repair of Crohn's related rectovaginal fistula.

Authors:  Galal El-Gazzaz; Tracy Hull; Emilio Mignanelli; Jeffery Hammel; Brook Gurland; Massarat Zutshi
Journal:  J Gastrointest Surg       Date:  2010-03-16       Impact factor: 3.452

2.  Operative results and quality of life after gracilis muscle transposition for recurrent rectovaginal fistula.

Authors:  J H Lefèvre; F Bretagnol; L Maggiori; A Alves; M Ferron; Y Panis
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

3.  Impact of perineal Crohn's disease on utilization of care in the absence of modifiable predictors of treatment failure.

Authors:  Abdulmetin Dursun; Richard Hodin; Liliana Bordeianou
Journal:  Int J Colorectal Dis       Date:  2014-10-02       Impact factor: 2.571

Review 4.  Management of Complex Perineal Fistula Disease.

Authors:  Ricardo Tadayoshi Akiba; Fabio Gontijo Rodrigues; Giovanna da Silva
Journal:  Clin Colon Rectal Surg       Date:  2016-06

5.  Gracilis muscle transposition for iatrogenic rectourethral fistula.

Authors:  Oded Zmora; Fabio M Potenti; Steven D Wexner; Alon J Pikarsky; Jonathan E Efron; Juan J Nogueras; Victor E Pricolo; Eric G Weiss
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  Functional and quality-of-life outcomes in patients undergoing transperineal repair with gracilis muscle interposition for complex rectourethral fistula.

Authors:  Mary K Samplaski; Hadley M Wood; Brian R Lane; Feza H Remzi; Armand Lucas; Kenneth W Angermeier
Journal:  Urology       Date:  2011-03       Impact factor: 2.649

7.  Gracilis muscle transposition for complex fistula and persistent nonhealing sinus in perianal Crohn's disease.

Authors:  Yasuko Maeda; Tina Heyckendorff-Diebold; Troels M Tei; Lilli Lundby; Steen Buntzen
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

8.  Gracilis muscle interposition for the treatment of rectourethral, rectovaginal, and pouch-vaginal fistulas: results in 53 patients.

Authors:  Steven D Wexner; Dan E Ruiz; Jill Genua; Juan J Nogueras; Eric G Weiss; Oded Zmora
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

9.  Gracilis muscle interposition for the treatment of recto-urethral and rectovaginal fistulas: a retrospective analysis of 35 cases.

Authors:  Dietmar Ulrich; Joachim Roos; Gerhard Jakse; Norbert Pallua
Journal:  J Plast Reconstr Aesthet Surg       Date:  2009-01-21       Impact factor: 2.740

10.  Gracilis muscle transposition for treatment of recurrent anovaginal, rectovaginal, rectourethral, and pouch-vaginal fistulas in patients with inflammatory bowel disease.

Authors:  S Korsun; G Liebig-Hoerl; A Fuerst
Journal:  Tech Coloproctol       Date:  2019-01-02       Impact factor: 3.781

View more
  2 in total

1.  Avoiding "dogma" ….

Authors:  F Dal Moro
Journal:  Tech Coloproctol       Date:  2020-10-17       Impact factor: 3.781

2.  Objective Perfusion Assessment in Gracilis Muscle Interposition-A Novel Software-Based Approach to Indocyanine Green Derived Near-Infrared Fluorescence in Reconstructive Surgery.

Authors:  Leonard A Lobbes; Richelle J M Hoveling; Leonard R Schmidt; Susanne Berns; Benjamin Weixler
Journal:  Life (Basel)       Date:  2022-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.